College of Public Health

3P Pharmaceuticals
Rodney Guttmann | 859.539.4219 | www.3ppharmaceuticals.com
3P Pharmaceuticals seeks to use peptide phage-display to develop biomarkers, research reagents, and therapeutics for multiple diseases and conditions. Their lead therapeutic peptide has been shown to be effective in blocking neuronal cell death and is under investigation in brain injury and related conditions.